Open AccessDermatomyositis‐lupus overlap syndrome complicated with cardiomyopathy after SARS‐CoV‐2 infection: A new potential trigger for musculoskeletal autoimmune disease development
Author(s) -
Shahidi Dadras Mohammad,
Rakhshan Azadeh,
Ahmadzadeh Arman,
Hosseini Seyed Ali,
Diab Reem,
Safari Giv Toktam,
Abdollahimajd Fahimeh
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4931
Subject(s) - medicine , dermatomyositis , covid-19 , systemic lupus erythematosus , overlap syndrome , disease , cardiomyopathy , myocarditis , immunology , autoimmune disease , pandemic , viral infection , dermatology , heart failure , virus , infectious disease (medical specialty)
Abstract COVID‐19 should be considered as a new triggering factor for autoimmune disorders like DM‐lupus overlap syndrome. We recommend that patients presenting with dermatomyositis during this pandemic be screened for COVID‐19.